MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPKα
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide and can develop to nonalcoholic steatohepatitis and later hepatic cirrhosis with a high prevalence to hepatocellular carcinoma. Oxidative stress and chronic hepatic inflammation are implicated in the...
Saved in:
| Main Authors: | Yuanjie Yu, Chunping He, Shiyun Tan, Mengjun Huang, Yitian Guo, Ming Li, Qian Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2021/4853355 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased RTN3 phenocopies nonalcoholic fatty liver disease by inhibiting the AMPK–IDH2 pathway
by: Hao Huang, et al.
Published: (2023-04-01) -
MicroRNA-34, microRNA-130, microRNA-148, microRNA-181, microRNA-194 and microRNA-605 expression in colon cancer tissue
by: D. I. Azovsky, et al.
Published: (2024-03-01) -
Evaluating the roles of microRNAs associated with nonalcoholic fatty liver disease in hepatocellular carcinoma tumorigenesis: a systematic review and network analysis
by: Qinghua Peng, et al.
Published: (2024-11-01) -
Nonalcoholic Fatty Liver Disease
by: Branka Filipović, et al.
Published: (2018-01-01) -
Exercise ameliorates nonalcoholic fatty liver disease by reducing the IGFBP5 to IGF1 ratio to activate AMPK pathway
by: Yang Yu, et al.
Published: (2025-07-01)